tirzepatide vs semaglutide comparison usa caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Curious about the differences between

Wegovy and Ozempic are prescription medications, and their availability can vary by country

Sales of the medicine, sold as Zepbound to treat obesity and Mounjaro for diabetes, topped $36 billion last year as it took market share away from Novo Nordisk's more established Wegovy/Ozempic treatment

Its glucagon receptor activation , though historically associated with hyperglycemia, is balanced by GLP-1 and GIP action , creating a net glycemic improvement

It can change the way people feel and live, too

In fact, patients who experience some initial nausea often show stronger weight loss outcomes because the medication is effectively activating appetite-suppressing pathways

Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery